United Therapeutics Corporation (UTHR) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
United Therapeutics (UTHR) Q1 2026: Relenopeg Data Signals Path to $8B+ Revenue Run Rate
May 06, 2026
-
United Therapeutics (UTHR) Q4 2025: Tyvaso DPI Grows 24% as Pipeline Launches Set Up $4B Run Rate
February 25, 2026
-
United Therapeutics (UTHR) Q3 2025: Tyvaso DPI Drives 7% Revenue Growth as IPF Pipeline Accelerates
October 29, 2025
-
United Therapeutics (UTHR) Q2 2025: Tyvaso DPI Grows 22% as Pipeline Catalysts Approach
July 30, 2025
-
United Therapeutics (UTHR) Q1 2025: Tyvaso-Driven 17% Growth Anchors Double-Digit Outlook Amid Pipeline Milestones
July 04, 2025